|
|
|
|
|
|
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
[Translation] Phase II clinical trial of tetrodotoxin injection in the treatment of severe cancer pain
评价替曲朵辛注射液与常规剂量的吗啡类镇痛药合并使用治疗癌性重度疼痛镇痛疗效和安全性。
[Translation] To evaluate the efficacy and safety of tetrodotoxin injection combined with conventional doses of morphine-like analgesics in the treatment of severe cancer pain.
100 Clinical Results associated with Nanning Maple Leaf Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Nanning Maple Leaf Pharmaceutical Co., Ltd.
100 Deals associated with Nanning Maple Leaf Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Nanning Maple Leaf Pharmaceutical Co., Ltd.